More on MDNA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Medicenna Therapeutics (NQ:MDNA)
Delayed: 0.16 --0 (-0%)
Prev. Close $0.16  
Open$32.44 
52 Wk High$ 
52 Wk Low$ 
Day High$0.16 
Day Low$0.16 
P/E N/A  
EPS$ 
Volume310,106 

Friends, Peers and Foes (?): MDNAF, PMN, TNGX, EDIT, APTO (more...)

May 28, 2026 09:10 AM Medicenna raises CDN$4.44 million in public offering of units
May 28, 2026 09:10 AM Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
May 22, 2026 07:00 AM Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet
May 19, 2026 07:00 AM Medicenna finalizes terms for public offering at $0.50 per unit
May 19, 2026 07:00 AM Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
May 13, 2026 04:01 PM Medicenna launches public offering to fund clinical programs
May 13, 2026 04:01 PM Medicenna Announces the Launch of a Marketed Public Offering of Securities
May 12, 2026 07:00 AM Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma
Apr 30, 2026 07:30 AM Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026
Apr 21, 2026 07:30 AM Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026
View All Articles

Entities mentioned with MDNA

View All Entities